0001193125-20-244338.txt : 20201014 0001193125-20-244338.hdr.sgml : 20201014 20200911194928 ACCESSION NUMBER: 0001193125-20-244338 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20200911 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Metacrine, Inc. CENTRAL INDEX KEY: 0001634379 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472297384 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 3985 SORRENTO VALLEY BLVD., SUITE C CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-369-7800 MAIL ADDRESS: STREET 1: 3985 SORRENTO VALLEY BLVD., SUITE C CITY: SAN DIEGO STATE: CA ZIP: 92121 CORRESP 1 filename1.htm CORRESP

September 11, 2020

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Mail Stop 4720

Washington, D.C. 20549-3628

 

Attn:

Courtney Lindsay, Celeste M. Murphy, Tracie Mariner, and Kevin Vaughn

 

Re:

Metacrine, Inc. (the “Company”) – Request for Acceleration

Registration Statement on Form S-1 (File No. 333-248292)

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), and as representatives of the several underwriters of the Company’s proposed public offering of common shares, we hereby join the Company’s request for acceleration of the above-referenced Registration Statement, as amended, requesting effectiveness for 4:30 p.m. Eastern Time on September 15, 2020, or as soon thereafter as is practicable.

Pursuant to Rule 460 of the Act, we wish to advise you that we have distributed approximately 635 copies of the Company’s Preliminary Prospectus dated September 9, 2020 through the date hereof to underwriters, dealers, institutions and others.

We, the undersigned, as representatives of the several underwriters, have complied and will continue to comply, and we have been informed by the participating underwriters that they have complied and will continue to comply, with the provisions of Rule 15c2-8 of the Securities Exchange Act of 1934, as amended.

[Signature Page Follows]

Very truly yours,
Jefferies LLC
Evercore Group L.L.C.
RBC Capital Markets, LLC

 

As representatives of the several Underwriters
By: Jefferies LLC
  By:  

/s/ Matthew Kim

  Name:   Matthew Kim
  Title:   Managing Director

 

By: Evercore Group L.L.C.
  By:  

/s/ Maren Winnick

  Name:   Maren Winnick
  Title:   Senior Managing Director

 

By: RBC Capital Markets, LLC
  By:  

/s/ Vincent Lozada

  Name:   Vincent Lozada
  Title:   Managing Director

 

[Signature Page to Acceleration Request Letter]